CAD pioneer partners with Sectra
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD technology, which is designed to assist radiologists in the early detection of breast cancer and has already been incorporated into digital mammography systems from other vendors, including GE Medical Systems. The two companies plan to integrate CAD not only into the MicroDose mammography system but also into Sectra PACS for Breast Imaging. Under the agreement, Sectra will have exclusive worldwide distribution rights for three years to R2's CAD technology as applied to Sectra's MicroDose mammography system. The system is based on a highly efficient digital detector technology, which promises to reduce radiation dose by 80% or more without affecting image quality. Sectra recently invested more than $11 million in Stockholm-based Mamea Imaging, developer of the novel detector technology and ergonomic imaging stand that make up Sectra's low-dose digital mammography system (SCAN 1/8/04).
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
